Viral-induced Adaptation of Neutrophil Response in ARDS
Viral-induced Adaptation of Neutrophil Response in ARDS
批准号:
7848627
负责人:
JERRY A NICK
金额:
$1.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2010-08-31
关键词:
Adult Respiratory Distress SyndromeBacteriaBacterial InfectionsBiological MarkersCellsChemotaxisChronicClinicalComplexDataDevelopmentDiseaseEnrollmentEventEvoked PotentialsExposure toGene ExpressionGene FamilyGenesImmune responseImmune systemImmunityImpairmentIndividualInfectionInflammatoryInjuryInterferon Type IInterferon-alphaInterferonsLifeLungLung InflammationMAPK14 geneMediatingModelingMusNational Heart, Lung, and Blood InstituteOutcomePathogenesisPatientsPhenotypePopulationPredictive ValuePropertyRiskRisk FactorsSamplingSeveritiesSeverity of illnessSignal TransductionStimulusTestingTherapeuticTherapy Clinical TrialsTimeTime StudyUp-RegulationViralVirusVirus DiseasesWhole Bloodabstractingchemokineclinically relevantdesigninterestneutrophiloutcome forecastpandemic diseasepathogenic bacteriaresponse
中文摘要
摘要
英文摘要
Abstract
The Acute Respiratory Distress Syndrome (ARDS) is a dysregulated response to a broad
range of infectious insults. However, tremendous variability in disease occurrence and severity
is seen between individuals with apparently similar risk factors. Rapid and massive
accumulation of neutrophils to the airspace is one of the first identifiable events in the
pathogenesis of ARDS, and overexuberant, ineffective, and/or inappropriate responses to a
bacterial infection may ensue. We hypothesize that viral infections can indirectly evoke a
transient impairment of the neutrophil response to pathogenic bacteria, resulting in enhanced
neutrophil-mediated lung inflammation and injury. Viruses induce the release of Type I
Interferons (IFNa/?), which in turn upregulate expression of a family of genes referred to as the
Interferon Stimulated Genes (ISG). In preliminary studies, we have found approximately one
quarter of patients at risk for ARDS demonstrate signficantly elevated ISG expression in their
circulating neutrophils, and that ISG upregulation is associated with an impaired neutrophil
response phenotype ex vivo and a more severe clinical outcome in patients. This hypothesis
will be tested in studies of isolated neutrophils and whole blood from ARDS patients that will be
enrolled in two upcoming therapeutic trials sponosored by the NHLBI ARDS Clinical Network.
The specific aims are to 1) Prospectively test in ARDS patients the effect of neutrophil
Interferon Stimulated Gene (ISG) upregulation on clinical parameters of disease severity and
outcome. 2) Prospectively test in neutrophils isolated from ARDS patients the effect of ISG
upregulation on cellular response to pro-inflammatory stimuli and live bacteria. 3) Prospectively
test in ARDS patients the predictive value of ISG upregulation in whole blood as a biomarker of
viral infection and a more severe clinical course. ISG upregulation in isolated neutrophils and
whole blood will be determined by real time PCR quantification of prototypical ISG, and analysis
of neutrophil signaling and functional properties central to an effective innate response to
bacterial infection. The proposal is ¿time sensitive¿, as neutrophil response must be analyzed
with viable cells at the time of isolation. Narrative
The capacity of ongoing, resolving or undiagnosed viral infections to predispose patients to
severe and often lethal bacterial infections has long been observed, but the mechanisms of
these events are largely unknown. If successful, this proposal will identify a mechanism by
which viruses can mediate a more severe outcome in ARDS, and will test the utility of elevated
ISG expression as a marker of worse prognosis. Identifying mechanisms by which viral-induced
dsyregulation of early immunity occurs is essential both to designing therapeutic strategies for
ARDS, and to interpret response to treatment in this remarkably complex condition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral-induced Adaptation of Neutrophil Response in ARDS
-
批准号:7870993
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2009
-
负责人:JERRY A NICK
-
依托单位:
Viral-induced Adaptation of Neutrophil Response in ARDS
-
批准号:7848366
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2007
-
负责人:JERRY A NICK
-
依托单位:
Viral-induced Adaptation of Neutrophil Response in ARDS
-
批准号:7356274
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2007
-
负责人:JERRY A NICK
-
依托单位:
Viral-induced Adaptation of Neutrophil Response in ARDS
-
批准号:7624167
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2007
-
负责人:JERRY A NICK
-
依托单位:
Regulation of Neutrophil Responses by p38 MAP Kinase in Acute Lung Injury
-
批准号:6553927
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2002
-
负责人:JERRY A NICK
-
依托单位:
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS
-
批准号:2027174
-
项目类别:
-
资助金额:$8.28万
-
财政年份:1997
-
负责人:JERRY A NICK
-
依托单位:
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS
-
批准号:2734978
-
项目类别:
-
资助金额:$8.28万
-
财政年份:1997
-
负责人:JERRY A NICK
-
依托单位:
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS
-
批准号:6388395
-
项目类别:
-
资助金额:$11.16万
-
财政年份:1997
-
负责人:JERRY A NICK
-
依托单位:
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS
-
批准号:6182394
-
项目类别:
-
资助金额:$11.16万
-
财政年份:1997
-
负责人:JERRY A NICK
-
依托单位:
LPS SIGNAL TRANSDUCTION IN NEUTROPHILS
-
批准号:6030391
-
项目类别:
-
资助金额:$11.16万
-
财政年份:1997
-
负责人:JERRY A NICK
-
依托单位:
Regulation of Neutrophil Responses by p38 MAP Kinase in Acute Lung Injury
-
批准号:7095863
-
项目类别:
-
资助金额:$25.22万
-
财政年份:--
-
负责人:JERRY A NICK
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: